Cargando…

Cost-Effectiveness of Clopidogrel vs Aspirin Monotherapy After Percutaneous Coronary Intervention: Results From the HOST-EXAM Study

BACKGROUND: The HOST-EXAM (Harmonizing Optimal Strategy for Treatment of Coronary Artery Disease–Extended Antiplatelet Monotherapy) trial showed superior efficacy and safety of clopidogrel monotherapy compared with aspirin monotherapy during the chronic maintenance period after percutaneous coronary...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hwang, Doyeon, Kim, Hea-Lim, Koo, Bon-Kwon, Rhee, Tae-Min, Yang, Dong-Wook, Seo, Youngwon, Byun, Joonsoo, Kang, Jeehoon, Han, Jung-Kyu, Park, Kyung Woo, Shin, Eun-Seok, Rha, Seung-Woon, Bae, Jang-Whan, Mamas, Mamas A., Cohen, David J., Lee, Tae-Jin, Kim, Hyo-Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167521/ https://www.ncbi.nlm.nih.gov/pubmed/37181388 http://dx.doi.org/10.1016/j.jacasi.2022.12.007

Ejemplares similares

Association of Clinical Outcomes With Sex in Patients Receiving Chronic Maintenance Antiplatelet Monotherapy After Percutaneous Coronary Intervention: A Post Hoc Gender Analysis of the HOST‐EXAM Study
por: Shin, Eun‐Seok, et al.
Publicado: (2023)

Comparative effect of clopidogrel plus aspirin and aspirin monotherapy on hematological parameters using propensity score matching
por: Hayasaka, Masatoshi, et al.
Publicado: (2013)

Clopidogrel versus Aspirin after Dual Antiplatelet Therapy in Acute Myocardial Infarction Patients Undergoing Drug-Eluting Stenting
por: Sim, Doo Sun, et al.
Publicado: (2019)

Dual Antiplatelet Therapy with Clopidogrel and Aspirin Versus Aspirin Monotherapy in Patients Undergoing Coronary Artery Bypass Graft Surgery
por: Qu, Jianyu, et al.
Publicado: (2021)

Aspirin and Clopidogrel Resistance
por: Sztriha, Laszlo K., et al.
Publicado: (2004)

Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Percutaneous Coronary Intervention: A Meta‐Analysis
por: Gelbenegger, Georg, et al.
Publicado: (2021)

The Effects of Preoperative Aspirin on Coronary Artery Bypass Surgery: a Systematic Meta-Analysis
por: Hwang, Doyeon, et al.
Publicado: (2019)

Comparison of Triple Anti-Platelet Therapy (Aspirin, Clopidogrel, and Cilostazol) and Double Anti-Platelet Therapy (Aspirin and Clopidogrel) on Platelet Aggregation in Type 2 Diabetic Patients Undergoing Drug-Eluting Stent Implantation
por: Yang, Tae-Hyun, et al.
Publicado: (2009)

Celecoxib Does Not Attenuate the Antiplatelet Effects of Aspirin and Clopidogrel in Healthy Volunteers
por: Lee, Wonjae, et al.
Publicado: (2010)

Benefits and Risks of Clopidogrel vs. Aspirin Monotherapy after Recent Ischemic Stroke: A Systematic Review and Meta-Analysis
por: Paciaroni, Maurizio, et al.
Publicado: (2019)

Aspirin Versus Clopidogrel Monotherapy for the Treatment of Patients with Stable Coronary Artery Disease: A Systematic Review and Meta-Analysis
por: Yuan, Jun, et al.
Publicado: (2019)

Efficacy and safety of clopidogrel versus aspirin monotherapy for secondary prevention in patients with coronary artery disease: a meta-analysis
por: Liu, Di, et al.
Publicado: (2023)

Aspirin and clopidogrel resistance: methodological challenges and opportunities
por: Gasparyan, Armen Yuri
Publicado: (2010)

Aspirin/clopidogrel: Lack of efficacy: case report
Publicado: (2020)

Clopidogrel plus Aspirin Use is Associated with Worse Long-Term Outcomes, but Aspirin Use Alone is Safe in Patients with Vasospastic Angina: Results from the VA-Korea Registry, A Prospective Multi-Center Cohort
por: Cho, Seong-Sik, et al.
Publicado: (2019)

Clopidogrel and Aspirin versus Aspirin Alone for Stroke Prevention: A Meta-Analysis
por: Tan, Shuai, et al.
Publicado: (2015)

Percutaneous Coronary Angioplasty in Patients with Cancer: Clinical Challenges and Management Strategies
por: Doolub, Gemina, et al.
Publicado: (2022)

Association Between Low Muscle Mass and Prognosis of Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Kim, Chi‐Hoon, et al.
Publicado: (2020)

Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy
por: Neubauer, Horst, et al.
Publicado: (2011)

The added value of hypertonic saline solution to furosemide monotherapy in patients with acute decompensated heart failure: A meta‐analysis and trial sequential analysis
por: Diaz‐Arocutipa, Carlos, et al.
Publicado: (2023)

Efficacy and safety of CYP2C19 genotype in stroke or transient ischemic attack patients treated with clopidogrel monotherapy or clopidogrel plus aspirin: Protocol for a systemic review and meta-analysis
por: Yao, Jia-Chen, et al.
Publicado: (2018)

Is clopidogrel superior to aspirin in secondary prevention of vascular disease?
por: Algra, Ale, et al.
Publicado: (2000)

Mapping the antiplatelet effects of clopidogrel and aspirin by modified thromboelastography
por: Hemlata,, et al.
Publicado: (2013)

Quantitative Flow Ratio and Virtual Percutaneous Coronary Intervention for Serial Coronary Stenoses: Attractive Technology, But Still Crawling
por: Sumaya, Wael, et al.
Publicado: (2022)

Complex, high‐risk percutaneous coronary intervention types, trends, and in‐hospital outcomes among different age groups: An insight from a national registry
por: Shamkhani, Warkaa, et al.
Publicado: (2022)

Aspirin in combination with clopidogrel in the treatment of acute myocardial infarction patients undergoing percutaneous coronary intervention
por: Zhang, Xiaoyan, et al.
Publicado: (2019)

Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting
por: Sharma, Rakesh K, et al.
Publicado: (2009)

Effects of Monotherapy with Clopidogrel vs. Aspirin on Vascular Function and Hemostatic Measurements in Patients with Coronary Artery Disease: The Prospective, Crossover I-LOVE-MONO Trial
por: Park, Hyun-Woong, et al.
Publicado: (2021)

Paraoxonase 1 Gene Polymorphism Does Not Affect Clopidogrel Response Variability but Is Associated with Clinical Outcome after PCI
por: Park, Kyung Woo, et al.
Publicado: (2013)

Impact of extracardiac vascular disease on outcomes of 1.4 million patients undergoing percutaneous coronary intervention
por: Bashar, Hussein, et al.
Publicado: (2022)

Is clopidogrel better than aspirin following breakthrough strokes while on aspirin? A retrospective cohort study
por: Lee, Meng, et al.
Publicado: (2014)

Cost‐Effectiveness of Clopidogrel‐Aspirin Versus Aspirin Alone for Acute Transient Ischemic Attack and Minor Stroke
por: Pan, Yuesong, et al.
Publicado: (2014)

The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]
por: Kulik, Alexander, et al.
Publicado: (2005)

Boosting platelet inhibition in poor responder to aspirin and clopidogrel undergoing percutaneous coronary intervention: role of tirofiban
por: Campo, Gianluca, et al.
Publicado: (2010)

Markers of hypercoagulability in CAD patients. Effects of single aspirin and clopidogrel treatment
por: Bratseth, Vibeke, et al.
Publicado: (2012)

Inability to Reverse Aspirin and Clopidogrel-induced Platelet Dysfunction with Platelet Infusion
por: Cohn, Stephen M, et al.
Publicado: (2019)

Measurement of Platelet Function in an Experimental Stroke Model With Aspirin and Clopidogrel Treatment
por: Lieschke, Franziska, et al.
Publicado: (2020)

Cerebral microbleeds in patients with ischemic cerebrovascular disease taking aspirin or clopidogrel
por: Ge, Lihong, et al.
Publicado: (2019)

Platelet Reactivity and Response to Aspirin and Clopidogrel in Patients with Platelet Count Disorders
por: Kuliczkowski, Wiktor, et al.
Publicado: (2021)

Prevalence of Aspirin and Clopidogrel Resistance in Patients with Recurrent Ischaemic Cerebrovascular Disease
por: Karunawan, Niyata Hananta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2p5t7sv5nm8f2kc4askqkngkdv